The first comprehensive long-term study comparing different medications for type 2 diabetes is launching nationwide. The GRADE (Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness) Study will compare the long-term benefits and risks of four widely used diabetes drugs in combination with metformin, the most common first-line medication for treating type 2 diabetes.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64578-grade-glycemia-reduction-approaches-in-diabetes-comparative-effectiveness
To announce the first-ever RC 350 sport coupe and RC F performance coupe, Lexus today launches a comprehensive marketing campaign that showcases the vehicles across a variety of media platforms. The RC/RC F marketing campaign mirrors the story of the coupe itself—which was built from a blank canvas, unconstrained by existing designs and convention—and is centered on the theme of shattering limits.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7341251-lexus-rc-350-sport-coupe-rc-f-performance-coupe/
Visit us at: http://www.leftasystems.org Online FTO Software will help you save time, money and resources for your agency. L.E.F.T.A.
is a comprehensive Field Training Software program that monitors the
field performance of law enforcement employees during their field
training curriculum and their probationary period.
Avoid Identity Theft Prevention and fraud with keepmyid.org. Comprehensive identity theft protection is only Identity Theft Protection Service from former law enforcement. Best ID theft Protection
NALCAB—National Association for Latino Community Asset Builders, today launched a National Fair Housing Media Campaign, to engage and inform African American, Latino, Asian Pacific Islanders and other communities about discriminatory housing practices, their rights under the federal Fair Housing Act, and HUD resources. This cutting-edge media campaign will engage people through a comprehensive national media effort as well as grassroots outreach.
To view Multimedia News Release, go to http://www.multivu.com/mnr/63685-nalcab-launches-campaign-against-housing-discrimination
Where to begin? Many guides on using Facebook for business focus on either inbound marketing or outbound marketing strategies, with little attention to analytics. In this video I will cover what I consider to be the most essential aspects of all three elements of marketing for Facebook. http://youtu.be/uV_LyPuk62o
Johnson & Johnson today announced the launch of Every Mother, Every Child, a comprehensive, five-year, private-sector effort to improve the health of women and children in developing countries. The initiative supports the United Nations’ April 2010 call for a renewed effort to achieve the Millennium Development Goals (MDGs) of reducing mortality in women and children by 2015.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/jnj/46066/
David Coba, CEO and co-founder of European Wax Center (EWC), the leader in the lifestyle beauty and waxing services categories, announced today the launch of Strut 365™, three collections of products designed to extend the EWC experience into your home. EWC’s mantra is Walk In, Strut Out…and now you can feel that way every day.
While many brands claim they know waxing, and others claim they know beauty products, only European Wax Center understands both. Strut 365 gives EWC guests the opportunity to really get gorgeous, every day, through their new collections; Strut Smoothly™, Strut Lavishly™, and Strut Boldly™. Whether you are searching for something to maintain gorgeous skin in-between waxes, something to seduce your senses while bringing out your skin’s natural radiance or something to achieve daily Browfection™ with, there is something in it for everyone, every day, in every collection. We have got you covered; lavishly, boldly, and smoothly!
“After years of intensive research and development, I’m beyond excited to see our vision for a beauty line come to fruition,” says Coba. “We have leveraged our team's expertise in scientifically formulated skincare products with efficacious ingredients to design a comprehensive line of products that will enhance the services offered in our centers and inspire confidence and gorgeous skin. It will allow our guests to bring European Wax Center with them wherever they go.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7815751-european-wax-center-launches-strut-365/
Ethicon*, a trusted leader in advancing wound closure, announces the launch of STRATAFIX™ Spiral PDS Plus and STRATAFIX™ Spiral Monocryl Plus Knotless Tissue Control Devices. With the addition of these two new suture technologies to the STRATAFIX™ Family of Knotless Tissue Control Devices, Ethicon has established the most comprehensive and unmatched knotless suture offering available to surgeons in the U.S.
STRATAFIX™ Knotless Tissue Control Devices transforms the wound closure experience by providing unique advantages over traditional sutures. STRATAFIX™ sutures provide more strength and security, more consistency and more efficiency than traditional suturing. The portfolio of knotless sutures also enables surgeons to more easily manage tension and control tissue approximation with each pass during closure and eliminates the need to tie knots.
To view the multimedia release go to:
http://www.multivu.com/players/English/7889651-ethicon-new-stratafix-suture/
Emdeon Inc., a leading provider of healthcare revenue and payment cycle management and clinical information exchange solutions, today announced the expansion of Emdeon Clinical Exchange™, its technology-enabled solution designed to improve business and clinical outcomes and care continuity.
Emdeon Clinical Exchange encompasses products and services that are designed to unite healthcare communities. Today, hospitals, physicians, labs, payers and pharmacies use Emdeon’s leading healthcare information network to securely exchange health information over six billion times annually. These healthcare stakeholders are demanding greater connectivity to each other and the ability to facilitate comprehensive, end-to-end clinical information exchange.
To view Multimedia News Release, go to http://www.multivu.com/mnr/48120-emdeon-expands-clinical-information-exchange-capabilities
The most detailed analysis yet of the role germline mutations in genes associated with cancer predisposition play in the development of childhood cancer suggests that comprehensive genomic screening may be warranted on all pediatric cancer patients, not just those with a family history of cancer. The study from the St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project appears in the November 19 edition of the New England Journal of Medicine.
Ultimately, researchers anticipate that systematic monitoring of patients and family members who have germline mutations in cancer predisposition genes will allow the detection of cancers at their earliest and most curable stage, thereby improving the outcomes for these children and family members.
To view the multimedia release go to:
http://www.multivu.com/players/English/7692851-st-jude-hospital-genome-project/
Lustgarten Foundation funded researchers at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins have designed a multi-analyte blood test that can detect the presence of pancreatic cancer as part of a panel of eight common cancers (pancreas, ovary, liver, stomach, esophagus, colorectum, lung and breast) as reported in the online edition of Science today. The test utilizes combined assays for genetic alterations and protein biomarkers and has the capacity not only to identify the presence of relatively early cancer, but also to localize the organ of origin of these cancers.
“The potential this has for pancreatic cancer is unprecedented,” says Anne Marie Lennon, M.D., Ph.D., Associate Professor of Medicine, Director, Pancreatic Cyst Center of the Ludwig Center at the Johns Hopkins Kimmel Cancer Center. “We know that in 80-85 percent of pancreatic cancer cases, it’s detected too late, leaving the patient with few options. Developing a blood screening test for pancreatic cancer has been an urgent goal, because catching the disease early will be the way we get to long-term survival.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8213751-lustgarten-foundation-pancreatic-cancer-blood-test/
